Combinations of radioprotectants spare radiation-induced damage to the physis

Clinical Orthopaedics and Related Research

Volumn 426, Issue , 2004, Pages 110-116

  Damron, Timothy A ^a,c   Spadaro, Joseph A ^a   Horton, Jason A ^a   Margulies, Bryan S ^a   Strauss, Judith A ^a   Farnum, Cornelia E ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b Animal Health Diagnostic Center   (United States)

^c Institute for Human Performance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; MISOPROSTOL; PENTOXIFYLLINE; RADIOPROTECTIVE AGENT; SELENIUM;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; BONE DENSITY; BONE GROWTH; BONE INJURY; BONE LONGITUDINAL GROWTH; CANCER RADIOTHERAPY; CHILDHOOD CANCER; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; GROWTH PLATE; LEG LENGTH INEQUALITY; MALE; MONOTHERAPY; MORTALITY; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RAT; SOFT TISSUE SARCOMA; TIBIA;

EID: 4444317262     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000131247.18112.0f     Document Type: Conference Paper

References (31)

1. Arguelles F, Gomar F, Garcia A, Esquerdo J: Irradiation lesions of the growth plate in rabbits. J Bone Joint Surg 59B:85-88, 1977.
2. Aygenc E, Celikkanat S, Bilgili H, et al: Pentoxifylline effects on acute and late complications after radiotherapy in rabbit. Otolaryngol Head Neck Surg 124:669-673, 2001.
3. Bianco J, Appelbaum F, Nemunaitis J, et al: Phase I-II trial of pentoxifylline for the prevention of transplant related toxicities following bone marrow transplantation. Blood 78:1205-1211, 1991.
4. Chua D, Lo C, Yuen J, Foo Y: A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol 24:366-369, 2001.
5. Damron T, Spadaro J, Horton J, et al: Novel radioprotectant drugs for sparing radiation-induced damage to the physis. Int J Radiat Biol, 2004. (In Press)
6. Damron TA, Margulies B, Biskup D, Spadaro JA: Amifostine before fractionated irradiation protects bone growth in rats better than fractionation alone. Int J Radiat Oncol Biol Phys 50:479-483, 2001.
7. Damron TA, Spadaro JA, Margulies B, Damron LA: Dose response of amifostine in protection of growth plate function from irradiation effects. Int J Cancer (Radiat Oncol Inv) 90:73-79, 2000.
8. Damron TA, Spadaro JA, Tamurian RM, Damron LA: Sparing of radiation-induced damage to the physis: fractionation alone compared to amifostine pretreatment. Int J Radiat Oncol Biol Phys 47:1067-1071, 2000.
9. 3-mediated effects on resting zone chondrocytes. J Cell Physiol 182:196-208, 2000.
10. Dion M, Hussey D, Doornbos J, et al: Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis. Int J Radiat Oncol Biol Phys 19:401-407, 1990.
11. Eifel PJ: Decreased bone growth arrest in weanling rats with multiple radiation fractions per day. Int J Radiat Oncol Biol Phys 15:141-145, 1988.
12. Eifel PJ, Sampson CM, Tucker SL: Radiation fractionation sensitivity of epiphyseal cartilage in a weanling rat model. Int J Radiat Oncol Biol Phys 19:661-664, 1990.
13. Grdina DJ, Kataoka Y, Murley JS: Amifostine: Mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol Drug Interact 16:237-279, 2000.
14. Hanson W: Radioprotection of muringe intestine by WR-2721, 16, 16 dimethyl prostaglandin E[-2] and the combination of both agents. Radiat Res 111:361-373, 1987.
15. Hanson W: Eicosanoid-Induced Radioprotection and Chemoprotection: Laboratory Studies and Clinical Applications. In Bump E, Malaker K (eds). Radioprotectors: Chemical, Biological, and Clinical Perspectives. New York, CRC Press, 197-212, 1997.
16. Hanson W, Zhen W, Geng L, Hunter N, Milas L: The prostaglandin E1 analog, misoprostol, a normal tissue protector, does not protect four murine tumors in vivo from radiation injury. Radiat Res 142:281-287, 1995.
17. Iwamoto M, Koike T, Nakashima K, Sato K, Kato Y: Interleukin 1: A regulator of chondrocyte proliferation. Immunol Lett 21:153-156, 1989.
18. Kinuya S, Yokoyama K, Konishi S, et al: Improved response of colon cancer xenografts to radioimmunotherapy with pentoxifylline treatment. Eur J Nucl Med 28:750-755, 2001.
19. Molteni A, Moulder J, Cohen E, et al: Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int J Radiat Biol 76:523-532, 2000.
20. Mutlu-Turkoglu U, Erbil Y, Oztezcan S, et al: The effect of selenium and/or vitamin E treatments on radiation-induced intestinal injury in rats. Life Sci 66:1905-1913, 2000.
21. Pateder DB, Sheu TJ, O'Keefe RJ, et al: Role of pentoxifylline in preventing radiation damage to epiphyseal growth plate chondrocytes. Radiat Res 157:62-68, 2002.
22. Raza A, Qawi H, Lisak L, et al: Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone. Blood 95:1580-1587, 2000.
23. Sankaranarayanan K. van Duyn-Goedhart A, de Rooij DG, van Buul PPW: Radioprotective effects of prostaglandins in V-79 Chinese hamster cells grown as spheroids in vitro and in mouse spermatogonial stem cells and bone marrow cells in vivo. Int J Radiat Biol 67:47-55, 1995.
24. Steel L, Walden Jr TL, Hughes HN, Jackson III WE: Protection of mice against mixed fission neutron-gamma (n: gamma = 1:1) irradiation by WR-2721, 16.16-dimethyl PGE2, and the combination of both agents. Radiat Res 115:605-608, 1988.
25. Steel L, Ledney G: Effects of Neutron Irradiation of PGE2 and T x B2 Levels in Biological Fluids: Modification by WR-2721. In Walden T, Hughes H (eds). Prostaglandins and Lipid Metabolism in Radiation Injury. New York, Plenum 207-218, 1987.
26. Stelzer K, Koh W, Kurtz H, Greer B, Griffin T: Caffeine consumption is associated with decreased severe late toxicity after radiation to the pelvis. Int J Radiat Oncol Biol Phys 30:411-417, 1994.
27. Tamurian RM, Damron TA, Spadaro JA: Sparing radiation-induced damage to the physis by radioprotectant drugs: Laboratory analysis in a rat model. J Orthop Res 17:286-292, 1999.
28. Weiss J, Hoover R, Kumar K: Selenium pretreatment enhances the radioprotective effect and reduces the lethal toxicity of WR-2721. Free Radic Res Commun 3:33-38, 1987.
29. Weiss J, Srinivasan V, Kumar K, Landauer M: Radioprotection by metals: Selenium. Adv Space Res 12:223-231, 1992.
30. Werner-Wasik M, Madoc-Jones H: Trental (pentoxifylline) relieves pain from postradiation fibrosis (letter). Int J Radiat Oncol Biol Phys 25:757-758, 1993.
31. Yuhas JM: A more general role for WR-2721 in cancer therapy. Br J Cancer 41:832-834, 1980.